Real-world outcomes of pembrolizumab plus carboplatin plus paclitaxel or nab-paclitaxel in non-small cell lung cancer (NSCLC). Tabah, A., Huggar, D., Kish, J., Bapat, B., Liassou, D., Gajra, A., Miller, T., Copher, R., Patel, M. LIPPINCOTT WILLIAMS & WILKINS. 2020

View details for Web of Science ID 000560368308227